[Testing and use of 9,9-dioxopromethazine (Prothanon) as an antihistaminic and antipruritic agent in dermatology].
D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D010919:Placebos; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy*; D012871:Skin Diseases / Q000188:drug therapy*
D003879:Dermatologic Agents; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010919:Placebos
Prüfung und Anwendung von 9.9-Dioxopromethazin (Prothanon) als Antihistaminicum-Antiprurituosum in der Dermatologie.